APP and schizophrenia: A meta-analysis [60] of data from 16 studies that compared APP with APM in patients with schizophrenia showed that APP reduced all psychotic symptoms, with a marked difference in the effect size (SMD −0.53, 95% confidence interval (CI) −0.87–−0.19), indicating the superiority of APP to APM.